Manuel Chaves
Overview
Explore the profile of Manuel Chaves including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Alfonso P, Chaves M, Munoz A, Salud A, Garcia-Gonzalez M, Gravalos C, et al.
BMC Cancer
. 2015 May;
15:327.
PMID: 25925749
Background: The optimal sequence of chemotherapeutic agents is not firmly established for the treatment of metastatic colorectal cancer (mCRC). This phase II multi-centre study investigated the efficacy and tolerability of...
2.
Lopez-Calderero I, Carnero A, Astudillo A, Palacios J, Chaves M, Benavent M, et al.
Hum Pathol
. 2014 Oct;
45(12):2437-46.
PMID: 25283475
Preclinical and clinical data suggest a protective role for estrogens on colon cancer (CRC) risk. estrogen receptor (ER) β is the prevalent ER in normal colonic mucosa, whereas its expression...
3.
Molina-Pinelo S, Carnero A, Rivera F, Estevez-Garcia P, Bozada J, Limon M, et al.
BMC Cancer
. 2014 Sep;
14:656.
PMID: 25197016
Background: MicroRNAs (miRNAs) are involved in numerous biological and pathological processes including colorectal cancer (CRC). The aim of our study was to evaluate the ability of miRNA expression patterns to...
4.
Sastre J, Aranda E, Massuti B, Tabernero J, Chaves M, Abad A, et al.
Crit Rev Oncol Hematol
. 2008 Dec;
70(2):134-44.
PMID: 19111473
Purpose: Healthy elderly patients with metastatic colorectal cancer may benefit from chemotherapy as much as the younger population. This analysis compares the outcomes of first-line oxaliplatin plus fluoropyrimidines in elderly...
5.
Diaz-Rubio E, Tabernero J, Gomez-Espana A, Massuti B, Sastre J, Chaves M, et al.
J Clin Oncol
. 2007 Jun;
25(27):4224-30.
PMID: 17548839
Purpose: The aim of this phase III trial was to compare the efficacy and safety of capecitabine plus oxaliplatin (XELOX) versus Spanish-based continuous-infusion high-dose fluorouracil (FU) plus oxaliplatin (FUOX) regimens...
6.
Borrega P, Velasco A, Bolanos M, Perez M, Mel J, Reina J, et al.
Urol Oncol
. 2004 Feb;
22(1):32-5.
PMID: 14969801
The purpose of this study was to investigate the efficacy and safety of combination chemotherapy using estramustine and vinorelbine in chemotherapy-naïve patients with hormone-resistant prostate cancer (HRPC). The patients (n...